Trader sentiment against a CDC Level 4 Travel Health Notice by December 31, 2026, reflects the complete absence of any active notices at that level and the lack of outbreaks meeting the agency's strict threshold for extreme health risk with no available precautions. Official CDC surveillance shows controlled threats, including a recent hantavirus cluster linked to a cruise ship that prompted only a Health Alert Network advisory with extremely low U.S. spread risk. Measles cases, while elevated, remain managed through vaccination, and notices for dengue, meningococcal disease, and yellow fever stay at Levels 1–2. With no evidence of rapidly escalating pathogens or healthcare system collapse, traders monitor routine CDC updates for shifts before year-end resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,475 Wol.
$71,475 Wol.
Dec 31, 2026
$71,475 Wol.
$71,475 Wol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader sentiment against a CDC Level 4 Travel Health Notice by December 31, 2026, reflects the complete absence of any active notices at that level and the lack of outbreaks meeting the agency's strict threshold for extreme health risk with no available precautions. Official CDC surveillance shows controlled threats, including a recent hantavirus cluster linked to a cruise ship that prompted only a Health Alert Network advisory with extremely low U.S. spread risk. Measles cases, while elevated, remain managed through vaccination, and notices for dengue, meningococcal disease, and yellow fever stay at Levels 1–2. With no evidence of rapidly escalating pathogens or healthcare system collapse, traders monitor routine CDC updates for shifts before year-end resolution.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Rynek otwarty: Jan 19, 2026, 3:15 PM ET
Wolumen
$71,475Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader sentiment against a CDC Level 4 Travel Health Notice by December 31, 2026, reflects the complete absence of any active notices at that level and the lack of outbreaks meeting the agency's strict threshold for extreme health risk with no available precautions. Official CDC surveillance shows controlled threats, including a recent hantavirus cluster linked to a cruise ship that prompted only a Health Alert Network advisory with extremely low U.S. spread risk. Measles cases, while elevated, remain managed through vaccination, and notices for dengue, meningococcal disease, and yellow fever stay at Levels 1–2. With no evidence of rapidly escalating pathogens or healthcare system collapse, traders monitor routine CDC updates for shifts before year-end resolution.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Wolumen
$71,475Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader sentiment against a CDC Level 4 Travel Health Notice by December 31, 2026, reflects the complete absence of any active notices at that level and the lack of outbreaks meeting the agency's strict threshold for extreme health risk with no available precautions. Official CDC surveillance shows controlled threats, including a recent hantavirus cluster linked to a cruise ship that prompted only a Health Alert Network advisory with extremely low U.S. spread risk. Measles cases, while elevated, remain managed through vaccination, and notices for dengue, meningococcal disease, and yellow fever stay at Levels 1–2. With no evidence of rapidly escalating pathogens or healthcare system collapse, traders monitor routine CDC updates for shifts before year-end resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania